Fussner @LynnFussner et al. DAH in PEXIVAS. DAH more freq younger, PR3+, relapsing, higher disease activity, higher creatinine. DAH more likely to die at 30 days and 1 year than those without DAH @RheumNow #ACR22 Abstr#0526 https://t.co/XGYHvDkVeA https://t.co/IEOcQHEQ3e
Links:
Characteristics and Outcomes of Participants with and Without Diffuse Alveolar …
https://acrabstracts.org/abstract/characteristics-and-outcomes-of-participants-…
12-11-2022
